Anthropic buys a one-person biotech and starts its own drug programmes
Anthropic announced the acquisition of Mithril Medicine, a one-person company founded by Cody Tranbarger that focuses on developing treatments for two rare forms of muscular dystrophy. Tranbarger has joined Anthropic as part of the deal. The acquisition terms were not disclosed. Alongside the acquisition, Anthropic revealed it has begun its own drug discovery initiatives, marking an expansion beyond its core AI focus into the life sciences sector.
Key points
- Anthropic acquires Mithril Medicine, a biotech firm working on rare muscular dystrophy treatments
- Founder Cody Tranbarger joins Anthropic; deal terms undisclosed
- Anthropic launches internal drug discovery programmes
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. The Next Web did the reporting; read the original for the full story.
Read the full story at The Next Web
